Table 4.
Serious adverse events
Adverse event | Control | Group A | Group B |
Deaths | 7 | 5 | 10 |
Nosocomial infection | 21 | 22 | 26 |
Heart rate and rhythm disorders | 3 | 2 | 2 |
Thrombocytosis | 1 | - | 1 |
Deep vein thrombosis | 2 | - | 1 |
Central nervous system disorders (new ischaemic or haemorrhagic stroke) | 3 | 2 | 2 |